Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Morimoto

Showing results (561-570 of 594) with videos related to

Pageof 60
Sort By:
Nature Genetics|March 31, 2000
The homeobox gene mirror links EGF signalling to embryonic dorso-ventral axis formation through notch activationK C Jordan, N J Clegg, J A Blasi, et al.
Japanese Circulation Journal|September 1, 1978
Serum enzymes in the differential diagnosis of acute myocardial infarctionI Yamasawa, M Morimoto, S I Konno, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 22, 2021
Epigenetic Biomarkers of Prenatal Tobacco Smoke Exposure Are Associated with Gene Deletions in Childhood Acute Lymphoblastic LeukemiaKeren Xu, Shaobo Li, Todd P Whitehead, et al.
American Journal of Epidemiology|April 24, 2020
History of Early Childhood Infections and Acute Lymphoblastic Leukemia Risk Among Children in a US Integrated Health-Care SystemLibby M Morimoto, Marilyn L Kwan, Kamala Deosaransingh, et al.
Oncogenesis|September 12, 2017
Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplicationY Ishikawa, K Nakayama, M Morimoto, et al.
Oncogenesis|September 13, 2019
Correction: Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplicationY Ishikawa, K Nakayama, M Morimoto, et al.
Arthritis and Rheumatism|April 21, 2011
Association of endogenous anti-interferon-α autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosusAlyssa M Morimoto, Donna Thibault Flesher, Jihong Yang, et al.
Veterinary and Comparative Oncology|September 17, 2009
Detection of centrosome amplification as a surrogate marker of dysfunction in the p53 pathway -p53 gene mutation or MDM2 overexpressionN Kaneko, M Okuda, N Toyama, et al.
Cancer Causes & Control : CCC|November 8, 2002
Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States)Libby M Morimoto, Emily White, Z Chen, et al.
Leukemia|September 9, 2024
Early-life tobacco exposure is causally implicated in aberrant RAG-mediated recombination in childhood acute lymphoblastic leukemiaTanxin Liu, Keren Xu, Anmol Pardeshi, et al.
Pageof 60

Showing results (561-570 of 594) with videos related to

Sort By:
Pageof 60
Nature Genetics|March 31, 2000
The homeobox gene mirror links EGF signalling to embryonic dorso-ventral axis formation through notch activationK C Jordan, N J Clegg, J A Blasi, et al.
Japanese Circulation Journal|September 1, 1978
Serum enzymes in the differential diagnosis of acute myocardial infarctionI Yamasawa, M Morimoto, S I Konno, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 22, 2021
Epigenetic Biomarkers of Prenatal Tobacco Smoke Exposure Are Associated with Gene Deletions in Childhood Acute Lymphoblastic LeukemiaKeren Xu, Shaobo Li, Todd P Whitehead, et al.
American Journal of Epidemiology|April 24, 2020
History of Early Childhood Infections and Acute Lymphoblastic Leukemia Risk Among Children in a US Integrated Health-Care SystemLibby M Morimoto, Marilyn L Kwan, Kamala Deosaransingh, et al.
Oncogenesis|September 12, 2017
Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplicationY Ishikawa, K Nakayama, M Morimoto, et al.
Oncogenesis|September 13, 2019
Correction: Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplicationY Ishikawa, K Nakayama, M Morimoto, et al.
Arthritis and Rheumatism|April 21, 2011
Association of endogenous anti-interferon-α autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosusAlyssa M Morimoto, Donna Thibault Flesher, Jihong Yang, et al.
Veterinary and Comparative Oncology|September 17, 2009
Detection of centrosome amplification as a surrogate marker of dysfunction in the p53 pathway -p53 gene mutation or MDM2 overexpressionN Kaneko, M Okuda, N Toyama, et al.
Cancer Causes & Control : CCC|November 8, 2002
Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States)Libby M Morimoto, Emily White, Z Chen, et al.
Leukemia|September 9, 2024
Early-life tobacco exposure is causally implicated in aberrant RAG-mediated recombination in childhood acute lymphoblastic leukemiaTanxin Liu, Keren Xu, Anmol Pardeshi, et al.
Pageof 60